BioNova Pharmaceuticals (Shanghai) LTD.
Quick facts
Phase 2 pipeline
- BN101 · Diabetes
BN101 is a small molecule that targets the SGLT2 receptor.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: